Theron Pharmaceuticals is a privately held biotechnology company developing a best-in-class, long acting M3 muscarinic antagonist (LAMA) for the improved treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma. The goal of Theron's LAMA program is to develop a once-daily inhaled bronchodilator that possesses the adequate physicochemical properties for broad inhalation device flexibility (DPI, MDI and nebulizer) in addition to excellent co-formulation compatibility for use in multi-drug combination products.
View Top Employees from Theron Pharmaceuticals, Inc.| Website | http://www.theronpharma.com |
| Revenue | $405000 |
| Employees | 1 (0 on RocketReach) |
| Founded | 2008 |
| Address | 365 San Aleso Ave, Sunnyvale, California 94085, US |
| Phone | (408) 792-7424 |
| Fax | (408) 744-6773 |
| Technologies |
ASP.NET,
Google Maps,
GoDaddy DNS
+4 more
(view full list)
|
| Industry | Biotechnology, Pharmaceutical Manufacturing, Manufacturing General, Drug Discovery, Manufacturing, Science and Engineering, Developer Platform, Software, Therapeutics, Health Care |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Theron Pharmaceuticals, Inc. employee's phone or email?
Theron Pharmaceuticals, Inc. Questions
The Theron Pharmaceuticals, Inc. annual revenue was $405000 in 2023.
Theron Pharmaceuticals, Inc. is based in Sunnyvale, California.
The NAICS codes for Theron Pharmaceuticals, Inc. are [3254, 32541, 32, 325].
The SIC codes for Theron Pharmaceuticals, Inc. are [283, 28].
Related Companies
